4.7 Review

Genome Editing Technologies as Cellular Defense Against Viral Pathogens

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.716344

关键词

genome editing; viral infectious disease; SARS-CoV-2; HIV; hepatitis B; emerging pathogen; RISPR/Cas

资金

  1. KAUST Office of Sponsored Research (OSR) [BAS/1/1080-01, REI/1/4742-01]

向作者/读者索取更多资源

Genome editing technologies play crucial roles in studying new treatments for viral infectious diseases, simplifying antiviral strategy design, and combating infections by a wide spectrum of viral pathogens including emerging coronaviruses. The technology can be used to efficiently eliminate latent infections and provide resistance to new infections.
Viral infectious diseases are significant threats to the welfare of world populations. Besides the widespread acute viral infections (e.g., dengue fever) and chronic infections [e.g., those by the human immunodeficiency virus (HIV) and hepatitis B virus (HBV)], emerging viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pose great challenges to the world. Genome editing technologies, including clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) proteins, zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs), have played essential roles in the study of new treatment for viral infectious diseases in cell lines, animal models, and clinical trials. Genome editing tools have been used to eliminate latent infections and provide resistance to new infections. Increasing evidence has shown that genome editing-based antiviral strategy is simple to design and can be quickly adapted to combat infections by a wide spectrum of viral pathogens, including the emerging coronaviruses. Here we review the development and applications of genome editing technologies for preventing or eliminating infections caused by HIV, HBV, HPV, HSV, and SARS-CoV-2, and discuss how the latest advances could enlighten further development of genome editing into a novel therapy for viral infectious diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据